Forte Biosciences (FBRX) IV bid into data

Forte Biosciences (NASDAQ: FBRX) August call option implied volatility is at 230, September is at 275; compared to its 52-week range of 87 to 265 into the expected release of FB-401 Phase 2 data in Atopic Dermatitis.

You May Also Be Interested In

• Intuitive Machines (LUNR) August 14 weekly calls active into quarter results
• Cerebras Systems (CBRS) call put ratio 1.1 calls to 1 put into quarter results
• Applied Materials (AMAT) call put ratio 1 call to 1.8 puts into quarter results